Thank you, Sharon Kedar, CFA Lucy Perez podcast on "Closing the $1 trillion (per annum) Women's Health Gap" (McKinsey & Company). It speaks to Temple Therapeutics two strategic axioms: 1. If the data does not represent you, it may not suit you. 2. If you cannot diagnose a disease, how can you treat it, develop products, or design trials? Temple Therapeutics, our three pillars—gynecological cancers, endometriosis, and fibrotic disorders—are supported by validated biobanks. This robust foundation allows us to lead a new era in precision medicine for women's health. We are dedicated to discovering new #biomarkers, #diagnostics, and disease-modifying treatments, truly redefining what is possible. #GynecologicalCancers #Endometriosis #FibroticDisorders #Biobanks #PrecisionMedicine #WomensHealth https://lnkd.in/gBsPbNbt
Temple Therapeutics
Biotechnologisch onderzoek
Geleen, - 726 volgers
Pioneering a new era in precision medicine for women's health
Over ons
A clinical-stage biotechnology company pioneering a female-focused precision medicine approach using validated biobanks for the discovery, development, and commercialization of novel therapeutics and companion diagnostics in women's health.
- Website
-
http://www.templerx.com
Externe link voor Temple Therapeutics
- Branche
- Biotechnologisch onderzoek
- Bedrijfsgrootte
- 2-10 medewerkers
- Hoofdkantoor
- Geleen, -
- Type
- Particuliere onderneming
- Opgericht
- 2015
- Specialismen
- ovarian cancer, endometrial cancer, fibrosis, endometriosis, post surgical adhesions, surgery, women's health, fitness, health, lifestyle, precision medicine, Artificial Intelligence, Machine Learning, Biobank, gynecology, reproductive medicine, infertility, cervical cancer, pcos, femtech, life sciences en healthcare
Locaties
-
Primair
Routebeschrijving
Urmonderbaan 22
Geleen, - 6167 RD, NL
Medewerkers van Temple Therapeutics
Updates
-
"If the data does not represent you, it may not suit you!" Historically, men have both led and been the subject of the study of #medicine and biology. What promise do precision medicine, biobank, and commitment hold to close the gap for the health of women? 👇 Temple Therapeutics uses validated biobanks of #female-specific tissues and blood, along with #clinical, #genetic, #ethnic, #prognostic, etc. to discover #biomarkers, #targetedtherapy, and advanced, #non-invasive #diagnostics. Follow us at Temple Therapeutics as we pioneer a new era in precision medicine for the health of women #womenhealth #venturecapital #gynecology #cancers #femtech #precisionmedicine #biobank #bioinformatics #endometriosis #ovariancancer #cervicalcancer #endometrialcancer #AACR Ru-fong Joanne Cheng, MD, FACOG Reenita Das Raysa Bousleiman Juan Camilo Arjona Ferreira Elke Bestel Ksenija Pavletic Ariel Belgrave Harris Anna Brailsford Anita Krohn Traaseth Carol Johnson Dr Claudia Pastides Elaine Pringle Schwitter Ghader Jamjoum Ilana Jacqueline Tamara CAIANI Louise Pentland Manal Rifki Najat Khan, PhD Lesley Stolz Kristi Campoe, PhD, RN, CMSRN, CPHQ, sMBA Kristin Stenerson Kristen Slawinski, PhD
-
"Early detection saves lives. Be thankful for your health this holiday season.” Chris Evert. Harnessing the power of #precisionmedicine for #earlydetection...👇 Temple Therapeutics is harnessing the power of #precisionmedicine and validated #biobanks that span diverse ethnicities and #histotypes to revolutionize our understanding of #ovariancancer and other #gynecology #cancers. 👍 2023 #breakthroughs: 1. April-#AACR- Dr. Ghassan Saed Khalil Helou Anna Portela Mestres revealed novel biomarker and therapeutic for ovarian cancer (https://lnkd.in/g44bY47q) (manuscript submitted) 2. Nov. 2023-Peer-reviewed publication Dr. Ghassan Saed ran 80-patient PoC trial demonstrating a compelling biomarker for #earlydetection of Stage 1 & 2 ovarian cancer (https://lnkd.in/gBQNnj6u) The achievements signify a pivotal stride in reshaping #patient #outcomes and propel Temple Therapeutics to the forefront of #ovariancancer, #diagnosis, #earlydetection, and novel targeted #therapeutics. Follow us Temple Therapeutics, comment, share this post, and help us in the pursuit of redefining what is possible for those battling #ovarian and other #gynecological #cancers. Let's meet up #jpm2024. Send me a personal message. Ovarian Cancer Research Alliance World Ovarian Cancer Coalition ESPN Sharsheret: The Jewish Breast & Ovarian Cancer Community Dr. Ghassan Saed Roche Genentech AbbVie AstraZeneca Organon Theramex GSK https://lnkd.in/gbNpJQtC
Tennis great Chris Evert re-diagnosed with cancer | CNN
cnn.com
-
Role of #Precision #Medicine in #Ovarian #Cancer Research? Advancements in #dnasequencing and #genomic profiling have significantly enhanced our ability to discern which individuals will positively respond to specific therapies. Within this landscape, #precisionmedicine plays a pivotal role in uncovering #noveltargets and #biomarkers. Temple Therapeutics is actively engaged in this transformative work, leveraging validated #biobanks that encompass diverse #histotypes. Recent publications from our research highlight promising biomarkers for #earlydetection (Stage I & II) and innovative targets (links provided in the comments below) signifying a crucial step toward reshaping #patient #outcomes and advancing the frontier of #ovariancancer discovery.
-
-
Temple Therapeutics Validated biobanks/precision medicine leads to #earlydetection #earlystage biomarker for ovarian cancer (https://lnkd.in/gghUkUym coupled with a novel target (presented at #AACR-https://lnkd.in/gJYZwutg) which seems to be agnostic to subtypes may provide another strategy to improve #ovarianpatient #outcomes. #ovariancancer Society for Women's Health Research (SWHR) Ovarian Cancer Research Alliance World Ovarian Cancer Coalition Roche Organon Ferring Pharmaceuticals https://lnkd.in/g-EVjQvd
Stort Tack till Cancerfonden, och Tack alla som skänker gåvor till forskningen och gör detta möjligt! Vårt projekt om äggstockscancer var ett av de 224 som fick anslag från @Cancerfonden! Projektet handlar om Klinisk betydelse av Lemur Tyrosine Kinase 3 (LMTK3) som potentiellt mål för behandling av äggstockscancer och vi hoppas kunna genom vår behandling med LMTK3-specifika antikroppar och peptider inducera celldöd av både cellgiftskänsliga resp. resistenta cancerceller utan att påverka normala celler. #tillsammansmotcancer #cancerfonden
-
#ovariancancer peer reviewed publication announcement! Lack of early-stage screening methods with high specificity, sensitivity, or both significantly contributes to the observed high mortality rates in #ovariancancer. In this report, we highlight mMPO as a potential biomarker for #earlydetection of #ovariancancer, which is critically needed. Temple Therapeutics we are committed to #womenhealth and improving #patient #outcomes. #ovariancancerawareness #earlydetection #ovarian #cancer #womenhealth Ovarian Cancer Research Alliance World Ovarian Cancer Coalition World Economic Forum https://lnkd.in/gghUkUym
Monomeric myeloperoxidase is a specific biomarker for early-stage ovarian cancer
tandfonline.com
-
Temple Therapeutics A clinical-stage biotechnology company pioneering a female-focused precision medicine approach for the discovery, development, and commercialization of novel therapeutics and companion diagnostics in reproductive medicine. We are redefining what is possible in women's health. It is a good start! #ovariancancer #endometriosis #adhesions #surgery #diagnostics #earlydetection #ACOG #ESHRE #ESGE #AAGL https://lnkd.in/gPs37t36
Remarks as Prepared for Delivery by First Lady Jill Biden on a Press Call Announcing White House Initiative on Women’s Health Research | The White House
whitehouse.gov
Vergelijkbare pagina’s
Door vacatures bladeren
Financiering
Temple Therapeutics
4 rondes in totaal
Bekijk meer informatie over Crunchbase
Laatste ronde
Schuldfinanciering
Externe Crunchbase-link voor laatste financieringsronde
US$ 325.000,00